Skip to main content

Lithium heparinised blood-collection tubes give falsely low albumin results with an automated bromcresol green method in haemodialysis patients.

Meng QH, Krahn J

Publication: Clin Chem Lab Med (2008) • Vol 46 • Page 396-400PMID: 18254716View on PubMed

Purpose

The purpose of this paper was to explain discrepant results obtained from a hemodialysis patient when plasma albumin quantification was performed by bromocresol green (BCG) versus the bromocresol purple (BCP) method.

Conclusion

No effect of in vivo treatment with heparin was found on albumin levels in serum, EDTA-plasma or heparinized plasma. However, collection of plasma into tubes containing lithium heparin resulted in a dose dependent decreased quantification of albumin by the BCG but not BCP method. No effect of quantification method was observed in EDTA-plasma or serum samples.

Studies (1)

Purpose

The purpose of this study was to determine the effects of in vivo heparin administration and collection anticoagulant on plasma and serum albumin levels by the BCG and BCP methods.

Summary of Findings

No effect of in vivo administration of heparin on albumin concentration in serum or plasma collected in EDTA, or heparinized tubes was observed in a single patient by either the BCP or the BCG method. However, collection of plasma in lithium heparin tubes resulted in significantly lower albumin levels by the BCG method than BCP in 30 non-renal patients (31.2 versus 34.1 g/L, p<0.001) and 30 hemodialysis patients (28.6 versus 32.8 g/L, p<0.001). The effect of heparin on plasma albumin levels was dose dependent. Heparinized plasma albumin levels were significantly lower from serum albumin levels only when quantified by BCG (31.2 versus 34.8 in non-renal patients p<0.001). Further, no effect of quantification method was observed on serum albumin levels. In conclusion, while in vivo heparin administration does not alter albumin quantification, the presence of lithium heparin in the collection tube caused decreased albumin quantification by the BCG but not BCP method.

  • Biospecimens

    FluidPlasma
    FluidSerum
    FluidBlood
  • Preservation Types

    None (Fresh)
  • Diagnoses

    Other diagnoses
    Normal
  • Platforms

    ProteinClinical chemistry/auto analyzer
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    PreaquisitionDiagnosis/ patient condition
    Renal failure on hemodialysis
    PreaquisitionOther drugs
    Heparin
    Biospecimen AcquisitionAnticoagulant
    EDTA
    Lithium heparin
    Biospecimen Aliquots and ComponentsBlood and blood products
    Plasma
    Serum
    Clinical chemistry/auto analyzer SpecificTechnology platform
    Bromocresol green (Roche)
    Bromocresol purple (Beckman)